ArticleViruses2023

Efficacy of Sotrovimab (SOT), Molnupiravir (MOL), and Nirmatrelvir/Ritponavir (N/R) and Tolerability of Molnupiravir in Outpatients at High Risk for Severe COVID-19.

Victoria Kauer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.